In fact, 6% of the US population (about 1 in 16 people) are currently taking GLP-1 medications
Adverse effects and challenges Short-term adverse effects, such as fatigue, irritability, headache, nausea, dehydration, hypoglycemia, diarrhea, metabolic acidosis, and refusal to eat, are commonly seen during the first few weeks of the KD as responses to diet-induced metabolic shift and are usually predictable and preventable
This situation is reversed in people with T2D where, although GIP secretion remains largely intact, GIP receptor activity is much reduced
DoSe Liposomal Glutathione contains Setria Reduced L-Glutathione, GSH, which is clinically proven to increase blood glutathione levels
Medical practitioners typically evaluate: Personal medical history Existing health conditions Potential side effects Some individuals may experience mild side effects at the beginning of treatment, which often subside over time